Ferrer; Marc

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ferrer; Marc.The latest application filed is for "selective d3 dopamine receptor agonists and methods of their use".

Company Profile

8.4.16

Ferrer; Marc - Potomac MD
Ferrer; Marc - Rockville MD
Ferrer; Marc - Madia PA
Ferrer, Marc - Media PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of low dose emetine for inhibition of human cytomegalovirus (HCMV) Grant 11,253,511 - Boger , et al. February 22, 2	2022-02-22
Autophagy inducers for treatment of CNS conditions Grant 11,241,436 - He , et al. February 8, 2	2022-02-08
Selective D3 Dopamine Receptor Agonists And Methods Of Their Use App 20210323941 - Sibley; David R. ; et al.	2021-10-21
Formulations And Methods For The Prevention And Treatment Of Tumor Metastasis And Tumorigenesis App 20210186972 - Rudloff; Udo ; et al.	2021-06-24
C-abl Tyrosine Kinase Inhibitory Compound Embodiments And Methods Of Making And Using The Same App 20210101872 - Marugan; Juan J. ; et al.	2021-04-08
Positive Allosteric Modulators Of Dopamine 1 Receptor And Method Of Use Thereof App 20210040074 - Sibley; David R. ; et al.	2021-02-11
Autophagy Modulators For Use In Treating Cancer App 20200369649 - DePamphilis; Melvin L. ; et al.	2020-11-26
Inhibitors Of Phosphoinositide 3-kinase And Histone Deacetylase For Treatment Of Cancer App 20200165257 - Grewal; Gurmit ; et al.	2020-05-28
Autophagy Inducers For Treatment Of Cns Conditions App 20200009146 - HE; Congcong ; et al.	2020-01-09
Heterocyclic compounds and methods of use thereof Grant 10,202,367 - Liang , et al. Feb	2019-02-12
Use Of Low Dose Emetine For Inhibition Of Human Cytomegalovirus (hcmv) App 20190022083 - Boger; Ravit ; et al.	2019-01-24
Heterocyclic Compounds And Methods Of Use Thereof App 20170114053 - Liang; Tsanyang ; et al.	2017-04-27
11-OXO-10,11-dihydrodibenzo[B,F][1,4]thiazepine S-oxide derivatives and their use as dopamine D2 receptor antagonists Grant 9,550,742 - Marugan , et al. January 24, 2	2017-01-24
Piperidine And Piperazine Derivatives And Their Use In Treating Viral Infections And Cancer App 20170001988 - Liang; Tsanyang Jake ; et al.	2017-01-05
11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepine S-oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists App 20160176831 - Marugan; Juan Jose ; et al.	2016-06-23
Inhibitors Of Eya2 App 20140155420 - Zhao; Rui ; et al.	2014-06-05
Assays to monitor amyloid precursor protein processing App 20060270841 - Espeseth; Amy S. ; et al.	2006-11-30
Biological assay detection method App 20050164311 - Inglese, James ; et al.	2005-07-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.